RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEW9E644CAED91407B3

https://w3id.org/ripe/ripe-kg/work/RIPEW9E644CAED91407B3
SubjectPredicateObject
ripekg:work/10.1016%2Fj.eururo.2013.04.001OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder
ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder dcterms:title Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder
ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder rdf:type node1
ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder rdf:type rdfs:Resource
ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder rdf:type owl:Thing
ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder rdf:type prov:Entity
ripekg:work/RIPEW9E644CAED91407B3Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder rdf:type ripe:WorkWork